Sex differences in bladder cancer: understanding biological and clinical implications
Prakash Chaudhary(Cedars-Sinai Medical Center), Xue Li(Cedars-Sinai Medical Center), Qin Ma(The Ohio State University), Debasish Sundi(The Ohio State University), Biplab Singha(Centre for Cellular and Molecular Biology), Sergei I. Grivennikov(Engelhardt Institute of Molecular Biology), Helen S. Goodridge(Cedars-Sinai Medical Center), Maria Velegraki(The Ohio State University), Anjun Ma(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Sungyong You(Cedars-Sinai Medical Center), Swati Satturwar(The Ohio State University), Anil V. Parwani(The Ohio State University Wexner Medical Center), Hany Abdel-Hafiz(University of Arizona), Yuzhou Chang(Shanghai Institute of Measurement and Testing Technology), Zihai Li(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Bin Zheng(Cedars-Sinai Medical Center), Dan Theodorescu(University of Arizona)
Cited by 17
Related Papers
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
|Science Translational Medicine|2014|5.1k
<i>TERT</i> promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal
|Proceedings of the National Academy of Sciences|2013|1.4k
Advances in bladder cancer biology and therapy
|Nature reviews. Cancer|2020|783
Naturally Occurring Human Urinary Peptides for Use in Diagnosis of Chronic Kidney Disease
|Molecular & Cellular Proteomics|2010|537